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ASPECTS OF THE RELATIONSHIP BETWEEN DRUG DOSE AND DRUG
EFFECT 
Abraham Peper  Department of Medical Physics, Academic Medical Centre,
University of Amsterdam, Amsterdam, The Netherlands
 It is generally assumed that there exists a well-defined relationship between drug dose
and drug effect and that this can be expressed by a dose-response curve. This paper argues
that there is no such clear relation and that the dose-response curve provides only limited
information about the drug effect. It is demonstrated that tolerance development during
the measurement of the dose-response curve may cause major distortion of the curve and
it is argued that the curve may only be used to indicate the response to the first adminis-
tration of a drug, before tolerance has developed. The precise effect of a drug on an indi-
vidual depends on the dynamic relation between several variables, particularly the level of
tolerance, the dose anticipated by the organism and the actual drug dose. Simulations
with a previously published mathematical model of drug tolerance demonstrate that the
effect of a dose smaller than the dose the organism has developed tolerance to is difficult
to predict and may be opposite to the action of the usual dose.
Keywords: Dose-response curve, drug tolerance, mathematical model, hormesis, homeopathy,
sensitization
INTRODUCTION
In previous publications, a model of drug tolerance and dependence
was presented (Peper et al. 1987, 1988; Peper and Grimbergen 1999; Peper
2004a, 2004b). The two 2004 papers present an advanced mathematical
model of intermittent adaptation describing the mechanism of tolerance
development and elaborate the theory underlying the model (Peper
2004a, 2004b). The model is essentially more complex than the generally
supported model of homeostasis, which has been demonstrated to fail in
describing tolerance development to repeated drug administrations
(Peper et al. 1987, Peper 2004a). The papers argue that tolerance to a
drug is not just tolerance to the properties of a certain drug, but tolerance
to a certain dose of that particular drug, and that the magnitude of the
compensatory response is not determined by the actual dose of the admin-
istered drug but by the dose the organism anticipates. In addition, the
papers argue that the oral recognition of exogenous substances is the nat-
ural and primary stimulus for the compensatory response in the tolerance
mechanism. Environmental cues are considered primary stimuli only in
dependence and addiction or when there is no oral stimulus such as when
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a drug is administered intravenously. Siegel’s theory of Pavlovian condi-
tioning describes how environmental cues may become associated with the
drug effect (Siegel et al. 1982; Siegel and Allan 1998; Siegel 1999).
In the present paper, the behaviour of the mathematical model with
respect to the dose-response relation will be examined further. The sim-
ulations carried out with the model demonstrate that when a level of tol-
erance has developed the relation between drug dose and drug effect is
very different from what is generally assumed. 
The paper discusses how the development of tolerance to a drug affects
the measurement of the dose response curve and indicates the serious con-
sequences tolerance development has for the applicability of the curve.
The effects of small doses are examined with regard to hormesis and home-
opathy. Sensitization and other paradoxical effects in the use of drugs are
discussed and possible explanations of these phenomena are given, relat-
ing them to changes in drug dose, the gain of the regulation loop and the
only gradual adaptation of the regulation to changing parameters.
The simulations show the effects of tolerance development on repeat-
ed drug administrations. For the tolerance mechanism to function, it must
be triggered when the drug is administered. For the behaviour of the math-
ematical model it is of no relevance whether the triggering takes place oral-
ly or by environmental cues and no distinction between different kinds of
triggering was made in the simulations. Whenever the paper discusses oral
drug administration, the drug is assumed to be gustatorily detectable.
A DYNAMIC MODEL OF THE DOSE-RESPONSE RELATION
A living organism is an immensely complex system of interconnected
processes. Most of these processes are regulated while they are at the
same time dependent on the functioning of other processes. It is difficult
to imagine how living organisms are able to achieve the incomprehensi-
bly complicated task of maintaining a balanced functioning in a continu-
ally changing environment. In 1878 Bernard wrote: “It is the fixity of the
‘milieu interieur’ which is the condition of free and independent life. All the vital
mechanisms however varied they may be, have only one object, that of preserving
constant the conditions of life in the internal environment“ (Bernard, 1878,
cited by Cannon, 1929). Cannon translated Bernard’s observation into
the model of homeostasis, which assumes physiological processes to main-
tain a steady state through feedback (Cannon 1929). An earlier publica-
tion (Peper 2004a) demonstrates that the model of homeostasis is not
adequate to describe the effect of repeated disturbances on the func-
tioning of living organisms and argues that, rather than maintaining a
steady state as Cannon proposed, living organisms are constantly striving
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for the best obtainable compromise in their functioning in constantly
changing circumstances. In this search for an optimum, the tolerance
mechanism plays an important role. When the organism is repeatedly dis-
turbed by a particular drug, it slowly learns to reduce the disturbing effect
of the drug by opposing the disturbance at the moment it occurs. In addi-
tion to this dynamic action, a lasting shift in functioning develops. In the
mathematical model described previously, these two activities are mod-
elled with a fast and a slow regulator respectively (Peper et al. 1987, 1988;
Peper 2004a, 2004b), illustrating the twofold effect of drugs. A drug not
only causes a direct, relatively short lasting effect, but it also fundamen-
tally changes the level of functioning of the processes involved.
A previous paper discusses the mathematical implementation of the
model (Peper 2004b). The mathematical model is a nonlinear, learning
feedback system, fully satisfying the principles of control theory. It accepts
any form of the stimulus—the drug intake—and describes how the phys-
iological processes involved affect the distribution of the drug through
the body. The 2004b paper addresses the complex structure of the com-
ponents of the regulation loop and derives the equations describing
them. The control-theoretical basis of the complete regulation loop is dis-
cussed as well as the conditions for its stability. 
In the following simulations with the mathematical model, the param-
eters have been chosen to obtain a clear picture of the effects. Because in
practice the stimulus—the drug intake—is extremely short in terms of the
repetition time, its duration has been extended for clarity. As the model is
a general model of tolerance development and does not describe a spe-
cific process, the vertical axes in the figures are in arbitrary units.
Fig. 1 shows a block diagram of a regulated adaptive process. The
process produces a hypothetical substance. Its regulation is disturbed by
FIG. 1. Block diagram of a regulated adaptive process.
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an exogenous substance of the same composition (see Peper 2004b). The
diagram comprises the digestive tract, the bloodstream, the process, the
process regulator and an adaptive regulator. When the exogenous substance
changes the level of the substance in the bloodstream the adaptive regu-
lator correct for this disturbance by readjusting the output level of the
process. The heavy arrows indicate the main route of the regulation loop.
The thin arrows indicate the route of the disturbance: the transfer of the
exogenous substance through the digestive tract to the bloodstream and
the transfer of the information about the presence of the substance to the
adaptive regulator.
When the exogenous substance enters the body, a series of activities
takes place to readjust the processes involved in order to reduce the dis-
turbance. Fig. 2 shows some signals from the block diagram which illus-
trate this mechanism (Peper 2004b). The endogenous substance is pro-
duced at a normally constant level, Lprocess. The resulting blood level is
FIG. 2. Some signals from the block diagram of Fig. 1 clarifying how tolerance develops: (a) The
exogenous substance when it enters the bloodstream, Sdigest. (b) Process output during tolerance
development, Sprocess. (c) Sprocess and Sdigest added in the blood stream and the resulting blood level,
Sblood, The level of the process output and the resulting blood level before the drug is administered
are Lprocess and Lblood.
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Lblood. When a similar substance is administered exogenously, the blood
level will be disturbed. When the exogenous substance is administered
repeatedly, the regulated process will develop tolerance to the distur-
bance. Trace (a) shows the exogenous substance, Sdigest, when it enters the
bloodstream. Trace (b) shows the process output: during the distur-
bances the output level will drop to counteract the induced rise in the
level of the substance in the blood. The signal representing this change
in process output level, Sprocess, represents the compensatory response of
the process to the disturbance. In addition to these temporary changes in
level, a permanent downward shift in the process output occurs. This shift
of the curve to a level substantially lower than the baseline, Lprocess, repre-
sents a fundamental change in the functioning of the processes involved.1
The two signals—Sdigest and Sprocess—are added when the endogenous and
exogenous substances mix in the bloodstream. The resulting signal is
shown in trace (c) together with the resulting blood level, Sblood, The dis-
turbance of the blood level gradually decreases during subsequent
administrations when the process regulator adapts to the recurrent dis-
turbance. Recall that all parameter settings in the simulations are arbi-
trary, as are the axes in the figure.
Fig. 2 demonstrates how the adaptive regulator learns to generate a
compensatory response when a drug is administered repeatedly. It slowly
learns to readjust the process parameters during the disturbance to coun-
teract the change in functioning caused by the drug. These readjust-
ments will start at the moment an exogenous substance is detected in the
mouth.2 The mouth analyses the substance and sends the acquired infor-
1This downward shift in the functioning of the process represents the drug induced
change in the functioning of processes involved in the drug effect, as discussed above. The shift
depends mainly on the functioning of the slow regulator which can have a long time constant.
Consequently, the shift may remain a long time after a drug is withdrawn. This has important
consequences as was first discussed in a previous paper (Peper et al. 1987): The negative shift of
the process output on drug withdrawal signifies the occurrence of antagonistic symptoms with respect to the
drug effect and these are consequently in the “direction” of the disorder the drug was intended to counter-
act (Kalant et al. 1971). This implies [...] a worsening of the disorder of the patient after termination of
drug treatment. Apparently, for the body, adaptation to a medicine means a shift in its function-
ing in the direction of the disease.
2As has been discussed extensively in Peper 2004a, the detection of exogenous substances
in the mouth is central to the process of tolerance development. The effect of the readjust-
ments of disturbed processes after a drug administration takes time, as most processes in the
body have a relatively slow response. If the body were to wait with counteracting the drug action
until it gets information from processes themselves that they have been disturbed, the toler-
ance mechanism would be too late to suppress the disturbance effectively. As the mouth is
where, in natural circumstances, exogenous substances enter the body, information from the
mouth actuates the readjustment of the involved processes. The mouth is equipped with all the
necessary means to detect and analyze exogenous substances. Taste—and, to a lesser extent,
smell—exist to provide the organism with the information it needs to organize its defense.
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mation to the processes which will be disturbed. This information is, how-
ever, restricted to the properties of the substance and does not include its
quantity. At the time of detection, the body cannot know how much of the
substance is to be administered and it has therefore developed a defence
mechanism in which the actual dose does not play a role. Instead, it bases
its defence on an assumed dose, the anticipated dose, which in most cases
will be approximately the average dose of recent drug deliveries (Peper et
al. 1988; Peper 2004a).
THE EFFECT OF CHANGES IN DRUG DOSE
Because the compensatory response is not based on the actual dose
but on the accustomed dose, the compensatory response will initially not
change when the actual dose is changed. The consequence is that a small
change in drug dose will have a disproportionately large effect (Peper et
al. 1988; Peper and Grimbergen 1999; Peper 2004a). Fig. 3 shows a sim-
ulation with the mathematical model of the effect of a small change in
drug dose after tolerance has developed. In the simulation, for a given set
of parameters, a 20 percent decrease in drug dose results in an initial sup-
pression of the drug effect. When the regulation adapts itself to the new
situation—it slowly learns to decrease the compensatory response—the
magnitude of the drug effect settles at a level reduced proportionally by
20 percent. When the dose is increased to its original magnitude, the
drug effect initially increases to approximately twice the normal level. 
FIG. 3. A simulation of the effect of a small change in drug dose after tolerance has developed. For
a given set of parameters, a 20 percent decrease in dose results in an initial suppression of the drug
effect. An increase in dose back to the original value causes an initial large increase in the drug effect.
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In Fig. 3, with the parameter values selected, a 20 % reduction in the
dose results in an initial reduction in the drug effect to zero. This implies
that at that moment the drug action and the compensatory response are
of equal magnitude (Sdigest and Sprocess in Fig. 2). When the dose is reduced
by more than 20 %, negative reactions occur as the compensatory
response then initially exceeds the action of the drug. This is shown in
Fig. 4, where the dose is reduced to 50 %. As was discussed in previous
papers, these large responses to small changes in drug dose are a com-
mon feature of the drug effect and are not restricted to the dependent
state (Peper et al. 1988; Peper 2004a).
THE DOSE-RESPONSE CURVE
Existing conceptualizations of the relationship between drug dose
and drug effect display fundamental contradictions. It is undisputed that
in dependent subjects a reduction in drug dose may generate large reac-
tions. At the same time, the dose-response curve (Fig. 5)—which postu-
lates that a change in drug dose will produce a proportionate and pre-
dictable change in drug effect—is assumed to provide an adequate
description of the dose-effect relation. The applicability of the dose-
response curve is limited because responses vary widely across subjects
(Ramsay and Woods 1997). But it also has other shortcomings. In stan-
dard medical practice the initial dose of a drug is selected on basis of the
dose-response curve of the drug and the characteristics and peculiarities
of the patient. If, after a few days, the effect is not as desired, the dose is
adjusted. If the dose-response curve were used to determine the new dose
FIG. 4. Effect of reduction in drug dose to 50 %.
7
Peper: Relationship between drug dose and drug effect
Published by ScholarWorks@UMass Amherst, 2014
Relationship between drug dose and drug effect
179
a problem would occur. During the administration of the drug, tolerance
may have developed and the curve will then have shifted to the right: an
increase in dose is required to obtain the same drug effect. In the exam-
ple given in Fig. 5, dose Ad, which causes drug effect Ae becomes ‘Ad for
the same drug effect after tolerance has developed. In the figure the shift
is arbitrarily large, but in reality the shift can also be substantial after a few
administrations of a drug and, due to the shift, curve (a) cannot be used
to determine another dose. If tolerance development can be estimated
and the curve is shifted to the right by the measured value, another diffi-
culty arises. Whereas from curve (a)—i.e. for the first dose—the drug
effect values Ae and Be can be determined from the drug dose values Ad
and Bd, after tolerance development a decrease in dose from ‘Ad to ‘Bd
will cause a decrease in the drug effect larger than curve (b) suggests. As
was demonstrated in Fig. 3, a reduction in the dose of a drug to which tol-
erance has developed may result in a disproportionate reduction in drug
effect. Even large reactions may occur as shown in Fig. 4. The latter is gen-
erally accepted in dependence. However, this effect in dependence does
not fundamentally differ from the effect when only tolerance is present,
as observed in earlier research. In dependence the effect is large because
tolerance in dependence is high. When tolerance is lower, as will be the
case after only a few drug administrations, the disproportionate effect of
a reduction in dose is smaller but the decrease in drug effect may initial-
ly still be significantly larger than predicted by the dose-response curve.
Positive overshoot when the drug dose is increased will be as large and
both situations may not be without risk to the patient.
The dose-response curve presumes a static relationship between drug
dose and drug effect. Yet, tolerance development—and thus time—is an
important factor in measuring the drug effect. This is demonstrated in sim-
ulations with the mathematical model shown in Fig. 6, where the dose and
FIG. 5. Drug dose—drug effect relation from the literature (a). Curve (b) shows the relation after
tolerance has developed.
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the drug effect are plotted separately against time to illustrate the influence
of tolerance development on dose-response curve measurements.
Usually, the dose-response curve is measured by increasing the dose in
logarithmic steps. The tolerance which develops during such a measure-
ment distorts the curve. This effect, however, is not very clear in the curve,
partly due to the distortion being gradual and partly due to the logarith-
mic change in dose.3 When the curve is determined with a decreasing
dose, the effect of tolerance development becomes readily apparent. To
demonstrate these effects, in Fig. 6 the dose is first increased and subse-
FIG. 6. Simulations with the mathematical model of the relation between dose (a) and drug effect,
plotted against time to illustrate the influence of tolerance development on the outcome of dose-
response curve measurements. The time constant of the tolerance mechanism in the simulations is
respectively 7 days (b), 30 days (c) and 400 days (d).
3The bend in the bottom of the dose-response curve is largely caused by the logarithmic
scale. In a linear process, a linear change in dose will cause a linear change in drug effect, as
long as there is no tolerance development (curve (d)). With a linear scale, distortion of the
curve due to tolerance development is easily noticed. However, as the dose-response curve is
commonly presented using a logarithmic dose scale, this has also been adopted here.
The saturation in the top of the dose-response curve in Fig. 4 is the natural maximal activ-
ity of the processes involved. This effect has been left out in the simulation of Fig. 5 as it has no
relevance to the subject discussed.
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quently decreased (a). In curve (b), representing the drug effect, a time
constant for the tolerance process is chosen of seven days (approximately
the time constant used in the simulations shown in previous papers on the
subject). The effect of the decrease in drug dose is a dramatic shift towards
a negative drug effect with symptoms opposite to the normal drug effect.
When the time constant is increased to 30 days (c), this effect is still very
strong. When the time constant is increased to 400 days (d), the effect has
nearly disappeared, leaving a curve where tolerance development does
not take place during measurement and the upward- and downward-slop-
ing portions of the curve have a similar shape.
The distortion of the curve during the increase in dose is significant.
The full implication of the effect of tolerance development, however,
becomes clear during the decrease in drug dose when the decrease in
drug action causes the compensatory response to become dominant and
the overall drug effect to turn negative.4 The dose-response curve is usu-
ally measured by increasing the dose, in which case no such reactions are
generated. But negative reactions are commonly seen in slow withdrawal
when the dose is tapered off too rapidly, a situation comparable to that
depicted in the figure. In the simulations, doses are administered once a
day, over 50 days in total. Simulations with other settings of the model
parameters, such as a different maximal dose, fewer stimuli or stimuli
with different time spacing gave a very similar picture.
The static representation of the relationship between drug dose
and drug effect suggested by the dose-response curve cannot be rec-
onciled with the dynamic responses of the organism to changes in drug
dose characteristic of the mechanism of tolerance development.
Unless tolerance to a certain drug develops very slowly, tolerance
development will distort the curve when the effect of different drug
doses is determined in a single subject. Values for the dose-response
curve should therefore be determined from the (averaged) responses
to single drug administrations measured in different subjects. Even
measured this way, a dose-response curve can only serve one valid pur-
pose: it shows the average relationship between the dose and the initial
response to a drug.
THE EFFECT OF SMALL DOSES
It was argued above that when the compensatory response exceeds the
drug action, negative reactions occur. This was demonstrated in Fig. 4 with
4As discussed, the distortion of the curve shown in the figure is caused by the development
of tolerance. The way the tolerance mechanism is triggered during this process—whether by
oral triggering or by environmental cues—is of no importance.
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a reduction of the dose to 50 %. When the dose is reduced even more, the
net result will be approximately the compensatory response alone, as is
shown in Fig. 7, where the dose is reduced to 10 %. A further reduction in
drug dose will give approximately the same negative effect, as the contri-
bution of this small dose to the total drug effect becomes negligible.
The negative reactions shown in Fig. 7 are not fundamentally differ-
ent from withdrawal reactions in dependence (Peper and Grimbergen
1999). In withdrawal, however, reactions occur because environmental
cues paired to the drug taking continue to trigger the compensatory
mechanism after the drug is withdrawn. When an exogenous substance is
taken orally and there are no environmental cues paired to the drug tak-
ing, the compensatory mechanism is not triggered when the administra-
tion of the drug is stopped and no reactions will occur (Peper et al. 1988;
Peper 2004a). When the administration of the drug is continued but the
dose is reduced, however, the compensatory mechanism will keep
responding at the moments when the drug is administered, as shown in
Figs 4 and 7. When the dose is sharply reduced, yet is still detected by the
organism, it is basically not the drug which induces these reactions but
the orally acquired information that the drug is present.
Not only oral administrations of small doses can evoke the responses
described above. Any stimulus able to trigger the compensatory mecha-
nism—like environmental cues and drug-onset cues (Kim et al. 1999;
FIG. 7. Effect of reduction in drug dose to 10 %.
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Sokolowska et al. 2002)—can cause reactions such as those shown in Fig.
7. In other words, the tolerance mechanism will respond, whether it is
triggered orally or by environmental cues. But, whereas the effects of
environmental cues and drug-onset cues can be crude and relatively
unpredictable (Siegel et al. 1982; Kim et al. 1999), the oral detection of
exogenous substances and the resulting stimulation of the compensatory
response is a highly sensitive and specialized mechanism, able to react to
very small doses. How triggering the compensatory response by means of
small doses can be used in withdrawal treatment in addiction was dis-
cussed in a previous publication (Peper and Grimbergen 1999).
HORMESIS AND HOMEOPATHY 
Hormesis has been defined as a bi-phasic dose-response relationship
in which the response at low doses is opposite to the effect at high doses.
Examples of opposite effects of drugs (and radiation) at low and high
doses can be found abundantly in the literature (Calabrese and Baldwin
2001, 2003; Conolly and Lutz 2004; Ali and Rattan 2006). Hormesis is usu-
ally explained by assuming a negative part in the dose-response curve at
the low dose end. Homeopathy claims a curative reaction from a small
dose of a drug of which high doses cause symptoms similar to those from
which the patient is suffering. A dose-dependent reverse drug effect is dif-
ficult to explain with existing models. In the proposed model this phe-
nomenon is an intrinsic component.
FIG. 8. The drug effect when a small dose is administered at an arbitrary time after the administra-
tion of a drug to which tolerance has developed is discontinued.
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In Figs 4 and 7, the dose was reduced abruptly. The resulting reac-
tions, however, do not depend on a sudden change in dose, but on the
difference between the actual dose and the dose to which the organism
has developed tolerance. Tolerance to a drug develops slowly and
remains present a long time. Fig. 8 depicts a simulation with the mathe-
matical model describing what happens when a small dose is adminis-
tered at an arbitrary time after the administration of a drug to which tol-
erance exists is discontinued. The figure shows that the small dose evokes
a reaction in the same way as the sudden reduction in dose simulated in
Figs 4 and 7. The drug dose in the figure of 10 % is arbitrary: as the actu-
al dose itself plays only a minor role in the remaining drug effect, any
small dose will cause approximately the same reaction as long as the body
recognizes the drug. Generally speaking, when there exists tolerance to a
substance, the effect of a small dose is limited to triggering the compen-
satory response, resulting in effects opposite to the normal drug effect.
SENSITIZATION AND OTHER PARADOXICAL EFFECTS
Fig. 3 shows that the large fall in drug effect in response to a decrease
in dose is followed by a rise in drug effect during subsequent drug admin-
istrations. The reduction in drug dose in this figure has been chosen to
obtain a large initial reduction in drug effect. However, any reduction in
dose after tolerance has developed will be followed by a rise in drug effect
until the organism has readjusted the magnitude of the compensa-
tory response to correspond with the action of the new drug dose. This
gradual increase in drug effect may explain cases of sensitization, a phe-
nomenon whereby the drug effect increases during repeated administra-
tions (Robinson and Berridge 1993; Everitt and Wolf 2002). Fig. 3
demonstrates the effect of abrupt changes in drug dose. As noted above,
tolerance to a drug remains present for a long time. When a drug has not
been administered over a certain period but tolerance has remained, or
when innate tolerance exists, a dose different from the dose to which tol-
erance exists will result in a similar effect and may also be the origin of
other paradoxical drug effects reported in the literature (Beasley et al.,
1991; Bauer 1996; George et al. 1997; Heisler and Tecott 2000; Wilens et
al. 2003). It should be observed that neither sensitization nor opposite
drug effects necessarily require tolerance to the administered drug as
cross tolerance to a related drug may cause similar effects.
Besides the drug dose, the magnitude of the compensatory response
also depends on other variables. The capacity of the body to suppress dis-
turbances—in the model domain represented by the open loop gain of
the regulation loop (Peper et al. 1988; Peper 2004b)—is of major impor-
tance. The latter parameter is not fixed but depends on health and age
(Mitchell et al. 1970; Verveen 1978, 1983; Peper et al. 1987, 1988; Peper
13
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2004a;). The consequence is that an individual’s level of tolerance to a
certain drug and the resulting drug effect may appear different in differ-
ent situations. This may mimic changes in drug dose with the conse-
quences discussed above and may be an additional cause of sensitization.
Rather than a loss of tolerance (Miller 2000) this might then constitute a
loss of the organism’s ability to express an acquired tolerance. 
In addition, the open loop gain may be affected by depressants and
stimulants and even by the effect of the administration of the drug itself.
Psychological factors, too, such as positive reinforcers may affect the open
loop gain, causing changes in the drug effect (Fillmore and Vogel-Sprott
1999; Grattan-Miscio and Vogel-Sprott 2005). As holds for small changes
in drug dose, small changes in the open loop gain can have large effects.
This is demonstrated in Fig. 9, where at the instant indicated with the
arrow, the gain of the regulation loop is increased by 20 %. There is an
instant decrease in the drug effect and even an adverse effect temporari-
ly appears. In the physiological regulation process, the gain is a distrib-
uted entity and the speed of change in the drug effect depends on where
in the regulation loop a change in gain occurs.
DISCUSSION
“People respond to food in the same way that they respond to exogenous drugs“
observed Woods in 1991 (Woods 1991). Yet the similarity he noticed has
not led to a general realization that for the body there is no fundamental
difference between food and other exogenous substances such as drugs:
they all disturb bodily processes and as a consequence induce tolerance
to their effect. In natural circumstances, exogenous substances enter the
body through the mouth and the function of the gustatory system must
be to recognize and analyse them before they can affect the functioning
FIG. 9. Decrease in drug effect after the gain of the regulation loop is increased by 20 %.
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of the body (Peper et al. 1988; Scott and Verhagen 2000; Peper 2004a).
The notion that the gustatory system triggers a compensatory response
when an exogenous substance is detected has been well established for
glucose (Fischer 1972; Deutsch 1974; Steffens 1976; Louis-Sylvestre 1978;
Grill et al. 1984; Dworkin 1993; Loewy and Haxhiu 1993).5 Much of the
research into the drug effect has been performed with intravenous drug
administrations which bypass the oral detection mechanism. When an
oral analysis of the substance is not available, the body uses environmen-
tal cues to trigger the tolerance mechanism. Although this has major dis-
advantages, demonstrated by for instance the potentially lethal conse-
quences of a change in environment in addicted subjects (Siegel et al.
1982; Siegel 1999), the body is able to develop tolerance. For the prob-
lems identified above concerning the dose-response curve, the way in
which the tolerance mechanism is triggered—directly by oral stimuli, or
indirectly, by environmental cues—is of no relevance. Tolerance develop-
ment will influence the dose-response relation, irrespective of how the
tolerance mechanism is triggered.
Research into the effect of repeatedly administered drugs has been
important and elucidating (Rescorla and Wagner 1972; Solomon and
Corbit 1973, 1974; Tiffany and Baker 1981; Wagner 1981; Siegel et al.
1982; Baker and Tiffany 1985; Tiffany and Maude-Griffin 1988; Poulos
and Cappell 1991; Dworkin 1993; Ramsay and Woods 1997; Heyne et al.
2000). Nevertheless, a lack of quantitative studies has meant a com-
mensurate lack of clarity concerning important characteristics of the
tolerance mechanism. The magnitude of the compensatory response,
in particular, has remained obscure, while it is a major parameter in
the overall drug effect. The magnitude of the compensatory response
is based on the dose to which the organism is accustomed and not on
the actual drug dose. This proposition was defended previously for the
oral administration of exogenous substances, but it is also evident for
intravenous drug administrations. When there is no oral stimulus, envi-
ronmental cues remain as a trigger for the compensatory response.
Information about the drug dose is not commonly part of a cue paired
to a drug administration, nor can the body obtain this information
physiologically in time to oppose the drug effect since injected drugs
can exert their effect very rapidly. Drug-onset cues, where the body
uses the onset of the drug effect as a trigger for the compensatory
response, do not contain information about the dose either.
5In the reaction of the body to oral glucose, the immediate, orally triggered, insulin secretion
is followed by a slow, extended insulin response which is related to the blood glucose level. In the
mathematical model this kind of effect is not incorporated.
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Consequently, there is no way for the body to acquire information
about the actual drug dose and its only option seems to be to base its
response on the dose it anticipates. 
That the model of homeostasis—or negative feedback—cannot
describe the effects of repeatedly administered drugs in a satisfactory way
was extensively discussed in a previous paper (Peper 2004a). Feedback
systems lack the capacity for learning, which is a vital tool in the develop-
ment of tolerance to repeated drug administrations (Thorpe 1956, Siegel
1983, Peper et al. 1987). Learning is the domain of adaptive processes and
in earlier work it was argued that the development of tolerance is an
adaptive process (Peper et al. 1988; Peper 2004a, 2004b). Although adap-
tive processes generally also use feedback, they constitute a class of regu-
lated processes essentially different from and much more complex than
feedback processes and the two should be kept distinct.
The meaning of the concept of homeostasis often seems so stretched
that it has become ambiguous (Toates 1979; Carpenter 2004). Usually it
is merely meant to indicate that a certain process is regulated. Many mod-
els are based on homeostasis without proof that they will work in the
assumed manner, as such models are rarely tested mathematically. Those
mathematical models that have been developed commonly investigate a
single disturbance only. Sometimes it is assumed that the homeostatic
concept will work for repeated disturbances when the model is made up
of complex combinations of feedback systems. However, no combination
of feedback systems can describe the effects of repeated disturbances.
Because feedback systems do not learn, every disturbance will evoke a
similar reaction, as was discussed in previous research (Peper 2004a).
Often qualities are attributed to homeostasis without proof that they sat-
isfy the principles of control theory (Carpenter 2004; Woods and Ramsey
2007; Siegel 2008). As stated before (Peper 2004b): ‘The behaviour of a reg-
ulated system can only be understood from the behaviour of a mathematical model
describing it. Even the behaviour of the simplest regulated system cannot be
described other than mathematically.’
The hypothesis underlying homeostasis—processes are kept at a
steady state by feedback—has widespread support. However, although
feedback can help to keep a process at a desired level, the open loop gain
of physiological processes is very small (Peper 2004b) and its effect in
dynamic forms of regulation will always be limited. In addition, a steady
state is difficult to define. It depends on the deviations considered accept-
able and on the accuracy of the measurement. When wide margins of
accuracy are accepted, the statement is always true but loses significance. 
An attempt to modify the model of homeostasis to account for its
obvious shortcomings is the model of allostasis (Sterling and Eyer 1988;
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Koob and Le Moal 2001; Ahmed et al. 2002; Schulkin 2003; Sterling
2004). Allostasis challenges the basis of homeostasis that processes func-
tion at a steady state and proposes that the goal of regulation is not con-
stancy, but rather, ‘fitness under natural selection’ (Sterling and Eyer,
1988; Sterling 2004). Yet, in spite of its criticism of the homeostatic
model, allostasis assumes that while the set points of process regulations
are controlled by the organism to meet its overall goal—efficiency—
these processes themselves are regulated in a homeostatic manner.
‘High-level interventions’ undoubtedly can play a significant role in the
regulation of processes (Sterling 2004), but these processes also have to
adapt to changes in the functioning of the numerous processes they
interact with and to disturbances to their functioning, caused for
instance by drugs. And it is the latter in particular where homeostasis
fails, as discussed above. That processes in the organism interact with
other processes, up to the highest level as allostasis asserts, is indis-
putable (Peper et al 1987, 1988, Peper et al. 1998; Peper 2004a), but the
regulation of processes at any level is necessarily adaptive, from cell level
up (Peper et al 1998).
The assumption that living organisms function on the basis of effi-
ciency is controversial. This premise is based on the concept of symmor-
phosis, which postulates that organs are ‘designed by nature’ to obtain an
optimal match of their capacities (Taylor and Weibel, 1981). The concept
of symmorphosis is however highly disputed (Garland and Huey, 1987;
Bennet 1988; Dudley and Gans 1991; Diamond and Hammond, 1992;
Alexander, 1998; Ricklefs, 1998; Harrison et al. 2001; Bacigalupe and
Bozinovic 2002; Dudley et al. 2006). Allostasis has substituted the goal of
homeostasis—a steady state—for optimal efficiency. But neither model
can explain the build-up of tolerance during repeatedly administered
drugs. Allostasis is predominantly a qualitative model.6 How the interac-
tion of the different processes in the control hierarchy should be mod-
elled mathematically to meet the goal of efficiency and allow for tolerance
development is not made clear and has never been tested quantitatively.
With regard to homeopathy, this paper does not go into the assumed
curative effect of small doses. However, it does show that a small dose of
a substance can cause reactions with symptoms opposite to the action of
the drug in high doses, a phenomenon that lies at the basis of homeopa-
thy. The small dose mentioned above does not refer to the infinitesimal
dose or high “potency” homeopathic medicines. On the other hand, the
6Ahmed and Koob (2005) set out a quantitative model in which considerations are based
on allostasis. The model is a homeostatic feedback system which controls the intravenous
administration of cocaine in rats.
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analysis shows that it is not the dose but the information about the pres-
ence of the substance that triggers the compensatory response. 
CONCLUSION
On the basis of simulations with a previously published mathematical
model of drug tolerance, the paper discusses different aspects of the rela-
tionship between drug dose and drug effect. The simulations show that
tolerance developing during the measurement of a dose-response curve
causes serious distortion of the curve. It is argued, furthermore, that the
dose-response curve should not be used after the first dose of a drug as a
curve cannot express the dynamic action of the tolerance mechanism. 
The effect of a certain dose of a certain drug on an individual is dif-
ficult to predict as it depends on several very different parameters, such
as the magnitude of the compensatory response, the level of tolerance,
the subject’s state of health and the history of drug administrations. The
simulations show that a dose of a drug smaller than the quantity the body
has tolerance to may generate symptoms opposite to the normal drug
effect, indicating that a negative drug effect is a natural phenomenon.
The only condition required to obtain a negative drug effect is that the
drug action is smaller that the compensatory response. This situation can
occur at any dose level, demonstrating that the relationship between the
drug dose and drug effect is much more complicated than is generally
assumed and can be captured in a curve.
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